GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) » Definitions » Change In Prepaid Assets

Shanghai Bio-heart Biological Technology Co (HKSE:02185) Change In Prepaid Assets : HK$-59.87 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Bio-heart Biological Technology Co Change In Prepaid Assets?

Shanghai Bio-heart Biological Technology Co's Change In Prepaid Assets for the quarter that ended in Dec. 2024 was HK$-8.27 Mil. It means Shanghai Bio-heart Biological Technology Co's Prepaid Assets declined by HK$8.27 Mil from Jun. 2024 to Dec. 2024 .

Shanghai Bio-heart Biological Technology Co's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was HK$-59.44 Mil. It means Shanghai Bio-heart Biological Technology Co's Prepaid Assets declined by HK$59.44 Mil from Dec. 2023 to Dec. 2024 .

Shanghai Bio-heart Biological Technology Co Change In Prepaid Assets Historical Data

The historical data trend for Shanghai Bio-heart Biological Technology Co's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Bio-heart Biological Technology Co Change In Prepaid Assets Chart

Shanghai Bio-heart Biological Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Prepaid Assets
Get a 7-Day Free Trial -3.73 -33.58 -48.87 55.71 -59.44

Shanghai Bio-heart Biological Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -54.53 17.97 37.73 -51.60 -8.27

Shanghai Bio-heart Biological Technology Co Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-59.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Bio-heart Biological Technology Co Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Shanghai Bio-heart Biological Technology Co's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Bio-heart Biological Technology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) » Definitions » Change In Prepaid Assets
Comparable Companies
HKSE:06628 HKSE:09939 HKSE:02126 HKSE:00690 HKSE:02496 HKSE:02898 HKSE:02257 HKSE:02197 HKSE:01244 HKSE:08158 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No.590 Ruiqing Road, Room 302, 3rd Floor, Building 4 & Building 6, East Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Website
http://www.bio-heart.com
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension.
Executives
Tpg Operating Group Ii, L.p. 2201 Interest of corporation controlled by you
Tpg Gp A, Llc 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Asia Vii Finance, Limited Partnership 2201 Interest of corporation controlled by you
Tpg Asia Vii Sf Pte. Ltd. 2101 Beneficial owner
Tpg Inc. 2201 Interest of corporation controlled by you
Tpg Group Holdings (sbs), L.p. 2201 Interest of corporation controlled by you
Tpg Holdings Iii-a, L.p. 2201 Interest of corporation controlled by you
Tpg Operating Group Iii, L.p. 2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii Gp Limited 2201 Interest of corporation controlled by you
Lc Fund Gp Limited 2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii, L.p. 2201 Interest of corporation controlled by you
Loft Success Investments Limited 2201 Interest of corporation controlled by you
Magic Grace Limited 2101 Beneficial owner
Proud Solar Limited 2201 Interest of corporation controlled by you

Shanghai Bio-heart Biological Technology Co Headlines

No Headlines